Medical and Wellness advisorS
Dr. Dana F. Flavin, born in Chicago, was deeply influenced by her parents, both doctors, who instilled in her a sense of compassion and duty. After earning degrees in Psychology and Chemistry from Loyola University, she pursued graduate studies in Pharmacology, and later worked as a Science Assistant at the FDA, researching cancer and tumor biology. She also studied Nutrient Biochemistry at Howard University and completed her medical degree in Innsbruck, Austria. Dr. Flavin's personal experiences with illness, including her own battles with epilepsy, a breast tumor, and a broken neck, strengthened her resolve to help patients and find cures for various diseases.

Her career has been marked by groundbreaking discoveries, including therapies for cancer, autoimmune diseases, and viral illnesses. Dr. Flavin has successfully reversed stage IV cancers and developed innovative treatments, such as a rapid cure for mononucleosis and a therapy that reverses brain metastases in breast cancer patients. She founded the Foundation for Collaborative Medicine and Research, where she continues to explore new therapies, blending conventional and complementary medicine. Her motto, “There is always a Treatment, we just have to find it,” reflects her lifelong dedication to relieving suffering and giving hope to patients around the world.
Dr. Dana F. Flavin
Pro. Li Dinggang
Professor Li Dinggang is a distinguished Chief Physician with over 40 years of experience in tumor treatment and regenerative medicine. He graduated from Nanjing Medical University in 1982 and has since held several prominent positions, including working at Beijing Friendship Hospital and conducting postdoctoral research at Johns Hopkins University. Throughout his career, he has pioneered advancements in gene biotherapy and tumor treatment, founding key centers for cancer gene therapy in China.

Professor Li’s expertise lies in designing personalized treatment plans for cancer patients, utilizing a multidisciplinary approach that integrates modern biological gene immunotherapy with traditional Chinese and Western medicine. His innovative application of minimally invasive techniques and cutting-edge therapies has drawn patients from around the world, earning him a reputation as a leader in cancer treatment. Currently, he serves as the Chief Clinical Expert at the Cell and Gene Therapy Research Center of Southern University of Science and Technology, where he continues to make significant contributions to the field.
© REGENCELL TECH CO., LTD.
2024